2018冷泉港亞洲會(huì)議：干細(xì)胞的交叉研究

 

 

裴端卿, 中科院廣州生物醫(yī)藥與健康研究院

Austin Smith, University of Cambridge, UK

Yasuhiro Yamada, The University of Tokyo, Japan 

 

1. Pluripotent stem cells
2. Embryos and chimaeras
3. Molecular reprogramming
4. Stem cell regulatory mechanisms
5. Tissue stem cells and niches
6. Stem cell models of development and disease
7. Stem cell therapies

 

Emma Andersson, Karolinska Institute, SWEDEN
Roger Barker, University of Cambridge, UK
Michele de Luca, University of Modena and Reggio Emilia, ITALY
Yukiko Gotoh, University of Tokyo, Graduate School of Pharmaceutical Sciences, JAPAN
Weiping Han, Institute of Molecular & Cell Biology, A*STAR, SINGAPORE
Danwei Huangfu, Memorial Sloan Kettering Cancer Center, USA
Naihe Jing（景乃禾）, 中科院上海生命科學(xué)研究院
Joo-Hyeon Lee, Cambridge Stem Cell Institute, UK
Jonathan Yuin-Han Loh, Institute of Molecular & Cell Biology, A*STAR, SINGAPORE
Hiroaki Okae, Tohoku University Graduate School of Medicine, JAPAN
Duanqing Pei（裴端卿）, 中科院廣州生物醫(yī)藥與健康研究院
Hirohide Saito, Kyoto university, JAPAN
Xiaohua Shen（沈曉驊）, 中國(guó)清華大學(xué)
Jose Silva, University of Cambridge, UK
Austin Smith, University of Cambridge, UK
Stephen Weiss, University of Michigan, USA
Marius Wernig, Stanford University, USA
Jun Wu, The University of Texas Southwestern Medical Center, USA
Yasuhiro Yamada, The University of Tokyo, JAPAN
Qi-Long Ying, University of Southern California, USA
Dahai Zhu（朱大海）, 中國(guó)醫(yī)學(xué)科學(xué)院

聯(lián)系方式： Cold Spring Harbor Asia No.299 Qiyue Road, SIP/ Suzhou, Jiangsu Province, China Tel: +86-512-62729029-1301 Fax: +86-512-62729028 Email: mikeji@csh-asia.org  Website: www.csh-asia.org